266 related articles for article (PubMed ID: 22420322)
1. The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats.
Hicks C; Jorgensen W; Brown C; Fardell J; Koehbach J; Gruber CW; Kassiou M; Hunt GE; McGregor IS
J Neuroendocrinol; 2012 Jul; 24(7):1012-29. PubMed ID: 22420322
[TBL] [Abstract][Full Text] [Related]
2. Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059.
Hicks C; Ramos L; Dampney B; Baracz SJ; McGregor IS; Hunt GE
Brain Res Bull; 2016 Oct; 127():208-218. PubMed ID: 27725169
[TBL] [Abstract][Full Text] [Related]
3. WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.
Hicks C; Ramos L; Reekie TA; Narlawar R; Kassiou M; McGregor IS
Psychopharmacology (Berl); 2015 Aug; 232(15):2659-67. PubMed ID: 25761839
[TBL] [Abstract][Full Text] [Related]
4. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.
Hunt GE; McGregor IS; Cornish JL; Callaghan PD
Brain Res Bull; 2011 Aug; 86(1-2):65-73. PubMed ID: 21745546
[TBL] [Abstract][Full Text] [Related]
5. Effects of oxytocin receptor antagonism on social function and corticosterone release after adolescent social instability in male rats.
Hodges TE; Eltahir AM; Patel S; Bredewold R; Veenema AH; McCormick CM
Horm Behav; 2019 Nov; 116():104579. PubMed ID: 31449812
[TBL] [Abstract][Full Text] [Related]
6. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
Ring RH; Schechter LE; Leonard SK; Dwyer JM; Platt BJ; Graf R; Grauer S; Pulicicchio C; Resnick L; Rahman Z; Sukoff Rizzo SJ; Luo B; Beyer CE; Logue SF; Marquis KL; Hughes ZA; Rosenzweig-Lipson S
Neuropharmacology; 2010 Jan; 58(1):69-77. PubMed ID: 19615387
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in oxytocin receptor binding in forebrain regions: correlations with social interest in brain region- and sex- specific ways.
Dumais KM; Bredewold R; Mayer TE; Veenema AH
Horm Behav; 2013 Sep; 64(4):693-701. PubMed ID: 24055336
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension.
Laporte R; Kohan A; Heitzmann J; Wisniewska H; Toy J; La E; Tariga H; Alagarsamy S; Ly B; Dykert J; Qi S; Wisniewski K; Galyean R; Croston G; Schteingart CD; Rivière PJ
J Pharmacol Exp Ther; 2011 Jun; 337(3):786-96. PubMed ID: 21411496
[TBL] [Abstract][Full Text] [Related]
9. Identification of an extracellular segment of the oxytocin receptor providing agonist-specific binding epitopes.
Hawtin SR; Howard HC; Wheatley M
Biochem J; 2001 Mar; 354(Pt 2):465-72. PubMed ID: 11171127
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin and vasopressin involved in restraint water-immersion stress mediated by oxytocin receptor and vasopressin 1b receptor in rat brain.
Zhao DQ; Ai HB
PLoS One; 2011; 6(8):e23362. PubMed ID: 21858088
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in oxytocin receptor expression and activation at parturition in the rat brain.
Meddle SL; Bishop VR; Gkoumassi E; van Leeuwen FW; Douglas AJ
Endocrinology; 2007 Oct; 148(10):5095-104. PubMed ID: 17628000
[TBL] [Abstract][Full Text] [Related]
12. Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus.
Hawtin SR; Wesley VJ; Parslow RA; Patel S; Wheatley M
Biochemistry; 2000 Nov; 39(44):13524-33. PubMed ID: 11063589
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin and vasopressin in the medial amygdala differentially modulate approach and avoidance behavior toward illness-related social odor.
Arakawa H; Arakawa K; Deak T
Neuroscience; 2010 Dec; 171(4):1141-51. PubMed ID: 20933576
[TBL] [Abstract][Full Text] [Related]
14. Conformationally rigid derivatives of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin-1a receptors.
Jorgensen WT; Gulliver DW; Katte TA; Werry EL; Reekie TA; Connor M; Kassiou M
Eur J Med Chem; 2018 Jan; 143():1644-1656. PubMed ID: 29126725
[TBL] [Abstract][Full Text] [Related]
15. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").
Thompson MR; Callaghan PD; Hunt GE; Cornish JL; McGregor IS
Neuroscience; 2007 May; 146(2):509-14. PubMed ID: 17383105
[TBL] [Abstract][Full Text] [Related]
16. Identification of oxytocin receptor activating chemical components from traditional Japanese medicines.
Maejima Y; Horita S; Yokota S; Ono T; Proks P; Yoshida-Komiya H; Ueta Y; Nishimori K; Misaka S; Shimomura K
J Food Drug Anal; 2021 Dec; 29(4):653-675. PubMed ID: 35649140
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic social defeat on behavioral and neural correlates of sociality: Vasopressin, oxytocin and the vasopressinergic V1b receptor.
Litvin Y; Murakami G; Pfaff DW
Physiol Behav; 2011 Jun; 103(3-4):393-403. PubMed ID: 21397619
[TBL] [Abstract][Full Text] [Related]
18. Role of the oxytocin system in amygdala subregions in the regulation of social interest in male and female rats.
Dumais KM; Alonso AG; Bredewold R; Veenema AH
Neuroscience; 2016 Aug; 330():138-49. PubMed ID: 27235738
[TBL] [Abstract][Full Text] [Related]
19. Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala.
László K; Kovács A; Zagoracz O; Ollmann T; Péczely L; Kertes E; Lacy DG; Lénárd L
Behav Brain Res; 2016 Jan; 296():279-285. PubMed ID: 26386304
[TBL] [Abstract][Full Text] [Related]
20. Centrally administered adrenomedullin 5 activates oxytocin-secreting neurons in the hypothalamus and elevates plasma oxytocin level in rats.
Otsubo H; Hyodo S; Hashimoto H; Kawasaki M; Suzuki H; Saito T; Ohbuchi T; Yokoyama T; Fujihara H; Matsumoto T; Takei Y; Ueta Y
J Endocrinol; 2009 Aug; 202(2):237-47. PubMed ID: 19420012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
